What is the role of CAR T-cell therapy in chronic lymphocytic leukemia (CLL)?

During SOHO 2019, Houston, US, Dr. Tanya Siddiqi from City of Hope Comprehensive Cancer Center, Duarte, US, spoke to the Lymphoma Hub about the potential of CAR T-cell therapy in chronic lymphocytic leukemia (CLL). She describes how those therapies, alone or in combination with ibrutinib, show efficacy in patients who relapse on small molecule inhibitors. She also highlights the recent report on the first set of patients, who received CAR T-cell therapy and continue to be in a complete remission nine years later.